Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,038 | -67,763 | -63,698 | -19,976 | 51,958 |
| Depreciation Amortization | 2,529 | 1,724 | 863 | 3,936 | 2,910 |
| Income taxes - deferred | 0 | 0 | 0 | N/A | 4,772 |
| Accounts receivable | 593 | -688 | 138 | -172 | -145 |
| Other Working Capital | -633 | -1,353 | -869 | 2,478 | 945 |
| Other Operating Activity | -26,521 | 50,342 | 53,228 | -16,783 | -85,282 |
| Operating Cash Flow | $-25,070 | $-17,738 | $-10,338 | $-30,517 | $-24,842 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -407 | -237 | -198 | -1,126 | -744 |
| Purchase Of Investment | N/A | N/A | N/A | -189 | N/A |
| Sale Of Investment | 3,215 | 3,215 | 3,215 | N/A | 0 |
| Other Investing Activity | -776 | -808 | -806 | -8,910 | -8,898 |
| Investing Cash Flow | $2,032 | $2,170 | $2,211 | $-10,225 | $-9,642 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 425 | 384 |
| Debt Repayment | -256 | -151 | -97 | -253 | -31 |
| Common Stock Issued | 6,000 | 5,737 | 737 | 59,707 | 30,122 |
| Common Stock Repurchased | -38 | -51 | -7 | -888 | 0 |
| Other Financing Activity | -26 | 0 | 0 | -3,600 | -1,463 |
| Financing Cash Flow | $5,680 | $5,535 | $633 | $55,391 | $29,012 |
| Exchange Rate Effect | -40 | -21 | 60 | 101 | 46 |
| Beginning Cash Position | 37,685 | 37,685 | 37,685 | 22,935 | 22,935 |
| End Cash Position | 20,287 | 27,631 | 30,251 | 37,685 | 17,509 |
| Net Cash Flow | $-17,398 | $-10,054 | $-7,434 | $14,750 | $-5,426 |
| Free Cash Flow | |||||
| Operating Cash Flow | -25,070 | -17,738 | -10,338 | -30,517 | -24,842 |
| Capital Expenditure | -399 | -237 | -198 | -1,326 | -930 |
| Free Cash Flow | -25,469 | -17,975 | -10,536 | -31,843 | -25,772 |